Dsc Advisors, L.P. Intercept Pharmaceuticals, Inc. Transaction History

Dsc Advisors, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$91.83 - $120.68 $918,300 - $1.21 Million	-10,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$60.0 - $85.67 $390,000 - $556,855	6,500 Added 185.71%	10,000 $839,000
Q4 2017 Feb 14, 2018	BUY	$58.2 - $72.76 $203,700 - $254,660	3,500	3,500 $204,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Dsc Advisors, L.P., based on Form 13F filings with the SEC.

Stay updated on Dsc Advisors, L.P. with notifications on news.